Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""metastasis"" wg kryterium: Temat


Starter badań:

Tytuł:
Visually predicting microRNA-regulated tumor metastasis by intracellularly 3D counting of fluorescent spots based on in situ growth of DNA flares.
Autorzy:
Xue C; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China.
Niu H; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China; Fujian Key Laboratory of Aptamers Technology, The 900(th) Hospital of Joint Logistics Support Force, Fuzhou 350025, China.
Hu S; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China.
Yang Z; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China.
Wang L; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China; Hunan Provincial Key Laboratory of Phytohormones and Growth Development, College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Wu ZS; Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Pharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou 350108, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of advanced research [J Adv Res] 2023 Jan; Vol. 43, pp. 73-85. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA*/chemistry
MicroRNAs*/chemistry
MicroRNAs*/metabolism
Neoplasm Metastasis*/diagnostic imaging
Neoplasm Metastasis*/genetics
Animals ; Humans ; Mice ; Apoptosis Regulatory Proteins/metabolism ; HeLa Cells/metabolism ; Nanotechnology/methods ; RNA-Binding Proteins ; Fluorescent Dyes/chemistry
Czasopismo naukowe
Tytuł:
Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors.
Autorzy:
Wang Z; Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Liu Q; Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. qianliu_.
Pokaż więcej
Źródło:
International journal of colorectal disease [Int J Colorectal Dis] 2023 Feb 13; Vol. 38 (1), pp. 37. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/pathology
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/pathology
Neoplasm Metastasis*
Humans ; Area Under Curve ; Calibration ; Prognosis ; SEER Program
Czasopismo naukowe
Tytuł:
The role of transient receptor potential channels in metastasis.
Autorzy:
Bai S; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
Wei Y; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
Liu R; School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, China.
Chen Y; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
Ma W; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
Wang M; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
Chen L; Department of obstetrics and gynecology, The Seventh Affiliated Hospital, Sun Yat-sen University, Zhenyuan Rd, Guangming Dist., Shenzhen, Guangdong 518107, China.
Luo Y; Longgang District People's Hospital of Shenzhen & The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China. Electronic address: .
Du J; Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Feb; Vol. 158, pp. 114074. Date of Electronic Publication: 2022 Dec 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/metabolism
Transient Receptor Potential Channels*/metabolism
Neoplasm Metastasis*
Humans ; Calcium/metabolism
Czasopismo naukowe
Tytuł:
Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity.
Autorzy:
Liu Z; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Choksi S; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Kwon HJ; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Jiao D; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Liu C; Transgenic Core, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Liu ZG; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło:
Breast cancer research : BCR [Breast Cancer Res] 2023 Jan 26; Vol. 25 (1), pp. 10. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Membrane Proteins*/metabolism
Necroptosis*
Breast Neoplasms*/pathology
Neoplasm Metastasis*
Animals ; Mice ; Cadherins ; Mice, Knockout ; Protein Kinases ; Receptor-Interacting Protein Serine-Threonine Kinases/metabolism ; Receptor-Interacting Protein Serine-Threonine Kinases/pharmacology ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Autorzy:
Biczok A; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany. .
Thorsteinsdottir J; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Karschnia P; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Ruf VC; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Herms J; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Schichor C; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Dorostkar MM; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.; Department of Pathology, University Clinic of St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Jan 14; Vol. 11 (1), pp. 12. Date of Electronic Publication: 2023 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Meningeal Neoplasms*/genetics
Meningeal Neoplasms*/pathology
Meningioma*/genetics
Meningioma*/pathology
Neoplasm Metastasis*/genetics
Humans ; Homozygote ; Mutation ; Retrospective Studies ; Sequence Deletion
Czasopismo naukowe
Tytuł:
ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer.
Autorzy:
Sun R; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Yuan L; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Jiang Y; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Wan Y; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Ma X; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Yang J; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Sun G; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Zhou S; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Wang H; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Qiu J; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Zhang L; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Cheng W; Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Pokaż więcej
Źródło:
Theranostics [Theranostics] 2023 Jan 05; Vol. 13 (2), pp. 833-848. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
AlkB Homolog 5, RNA Demethylase*/genetics
AlkB Homolog 5, RNA Demethylase*/metabolism
Focal Adhesion Protein-Tyrosine Kinases*/metabolism
Lymphangiogenesis*/genetics
Lymphatic Metastasis*
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Carcinoma, Ovarian Epithelial/genetics ; Demethylation ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Autorzy:
Lou Y; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Chen D; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Lin Z; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Sun J; Department of Radiotherapy, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Song L; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Chen W; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Zhang M; Department of Nuclear Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China.
Chen Y; Department of Radiotherapy, Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou, China. .
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 Jan; Vol. 280 (1), pp. 347-356. Date of Electronic Publication: 2022 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphatic Metastasis*/diagnostic imaging
Lymphatic Metastasis*/pathology
Nasopharyngeal Carcinoma*/diagnosis
Nasopharyngeal Carcinoma*/pathology
Nasopharyngeal Carcinoma*/therapy
Humans ; Fluorodeoxyglucose F18 ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Nasopharyngeal Neoplasms/diagnosis ; Nasopharyngeal Neoplasms/pathology ; Nasopharyngeal Neoplasms/therapy ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods ; Prognosis ; Radiopharmaceuticals ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
Autorzy:
Jiang J; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Chen HN; Colorectal Cancer Center, Department of General Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.
Jin P; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Zhou L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.
Peng L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.
Huang Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.
Qin S; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.
Li B; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.
Ming H; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Luo M; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China.; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Xie N; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Gao W; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China.
Nice EC; Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Yu Q; Cancer Precision Medicine, Genome Institute of Singapore, Agency for Science, Technology, and Research, Biopolis, Singapore, 138672, Singapore.
Huang C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China. .; West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, P.R. China. .
Pokaż więcej
Źródło:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Feb 15; Vol. 8 (1), pp. 65. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*
Tumor Suppressor Protein p53*/genetics
Transaminases*/genetics
Neoplasm Metastasis*/prevention & control
Humans ; Codon ; Polymorphism, Single Nucleotide ; Animals
Czasopismo naukowe
Tytuł:
The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review.
Autorzy:
Łabędź W; Adult Spine Orthopaedics Department, Poznan University of Medical Sciences, 61-545 Poznan, Poland.
Przybyla A; Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Zimna A; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Dąbrowski M; Adult Spine Orthopaedics Department, Poznan University of Medical Sciences, 61-545 Poznan, Poland.
Kubaszewski Ł; Adult Spine Orthopaedics Department, Poznan University of Medical Sciences, 61-545 Poznan, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 14; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Bone Neoplasms*/metabolism
Bone Neoplasms*/secondary
Cytokines*/metabolism
Neoplasm Metastasis*/physiopathology
Humans ; Male ; Chemokine CXCL12 ; Ligands ; Receptors, CXCR4/metabolism ; Receptors, Cytokine/metabolism ; Transforming Growth Factor beta
Czasopismo naukowe
Tytuł:
Slow TCA flux and ATP production in primary solid tumours but not metastases.
Autorzy:
Bartman CR; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Weilandt DR; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Shen Y; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.
Lee WD; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.
Han Y; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
TeSlaa T; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.; Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA.
Jankowski CSR; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Samarah L; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Park NR; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
da Silva-Diz V; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Aleksandrova M; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Gultekin Y; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Boston, MA, USA.
Marishta A; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Wang L; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.; Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yang L; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.; Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Shanghai, China.
Roichman A; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Bhatt V; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Lan T; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Hu Z; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Xing X; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Lu W; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.
Davidson S; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.
Wühr M; Department of Chemistry, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Boston, MA, USA.
Herranz D; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Guo JY; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Kang Y; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Rabinowitz JD; Department of Chemistry, Princeton University, Princeton, NJ, USA. .; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA. .; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Feb; Vol. 614 (7947), pp. 349-357. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Adenosine Triphosphate*/biosynthesis
Adenosine Triphosphate*/metabolism
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Citric Acid Cycle*/physiology
Deceleration*
Lung Neoplasms*/metabolism
Lung Neoplasms*/secondary
Neoplasm Metastasis*
Pancreatic Neoplasms*/metabolism
Pancreatic Neoplasms*/pathology
Animals ; Mice ; Energy Metabolism ; Glycolysis ; Organ Specificity ; Protein Biosynthesis
Czasopismo naukowe
Tytuł:
Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer.
Autorzy:
Tong P; Department of Radiology, Jiangnan University Medical Center, Wuxi, 214000, Jiangsu, China.
Sun D; Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
Chen G; Department of Radiology, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Ni J; Department of Radiology, Jiangnan University Medical Center, Wuxi, 214000, Jiangsu, China. .
Li Y; Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 18; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Magnetic Resonance Imaging*/methods
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/surgery
Rectal Neoplasms*/pathology
Lymphatic Metastasis*/diagnostic imaging
Humans ; Diffusion Magnetic Resonance Imaging/methods ; Retrospective Studies ; ROC Curve ; Neoplasm Invasiveness
Czasopismo naukowe
Tytuł:
Extracellular vesicles in the development of organ-specific metastasis.
Autorzy:
Urabe F; Department of Urology The Jikei University School of Medicine Tokyo Japan.; Department of Molecular and Cellular Medicine Tokyo Medical University Tokyo Japan.
Patil K; Department of Molecular Pathophysiology Translational Research Institute Academic Health System Hamad Medical Corporation Doha Qatar.
Ramm GA; Department of Cell and Molecular Biology QIMR Berghofer Medical Research Institute Brisbane Queensland Australia.; School of Biomedical Sciences Faculty of Medicine University of Queensland Brisbane Queensland Australia.
Ochiya T; Department of Molecular and Cellular Medicine Tokyo Medical University Tokyo Japan.
Soekmadji C; Department of Cell and Molecular Biology QIMR Berghofer Medical Research Institute Brisbane Queensland Australia.; School of Biomedical Sciences Faculty of Medicine University of Queensland Brisbane Queensland Australia.
Pokaż więcej
Źródło:
Journal of extracellular vesicles [J Extracell Vesicles] 2021 Jul; Vol. 10 (9), pp. e12125. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:
Neoplasm Metastasis*
Extracellular Vesicles/*metabolism
Animals ; Bone Neoplasms/metabolism ; Bone Neoplasms/secondary ; Brain Neoplasms/metabolism ; Brain Neoplasms/secondary ; Humans ; Liver Neoplasms/metabolism ; Liver Neoplasms/secondary ; Lung Neoplasms/metabolism ; Lung Neoplasms/secondary ; Lymphatic Metastasis
Czasopismo naukowe
Tytuł:
Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis.
Autorzy:
Siriphak S; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.
Chanakankun R; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.
Proungvitaya T; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.
Roytrakul S; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani 12120, Thailand.
Tummanatsakun D; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.
Seubwai W; Cholangiocarcinoma Research Institute, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Department of Forensic Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Wongwattanakul M; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.
Proungvitaya S; Centre of Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, KhonKaen University, Khon Kaen 40002, Thailand.; Cholangiocarcinoma Research Institute, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2021 May 22; Vol. 26 (11). Date of Electronic Publication: 2021 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphatic Metastasis*
Biomarkers, Tumor/*blood
Cholangiocarcinoma/*drug therapy
Membrane Proteins/*blood
Serine Endopeptidases/*blood
Cell Line, Tumor ; Cholangiocarcinoma/pathology ; Computational Biology ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Ligands ; Neoplasm Metastasis ; Prognosis ; Protein Binding ; Protein Domains ; Protein Interaction Mapping ; Signal Transduction
Czasopismo naukowe
Tytuł:
Clinicopathological factors associated with synchronous distant metastasis and prognosis of stage T1 colorectal cancer patients.
Autorzy:
Li Q; Department of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), 1 Banshan East Road, Hangzhou, 310022, Zhejiang, China.
Wang G; Department of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), 1 Banshan East Road, Hangzhou, 310022, Zhejiang, China.
Luo J; Department of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), 1 Banshan East Road, Hangzhou, 310022, Zhejiang, China.
Li B; Department of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), 1 Banshan East Road, Hangzhou, 310022, Zhejiang, China.
Chen W; Department of Colorectal Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), 1 Banshan East Road, Hangzhou, 310022, Zhejiang, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 22; Vol. 11 (1), pp. 8722. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Metastasis*
Colorectal Neoplasms/*pathology
Biomarkers, Tumor/blood ; Carcinoembryonic Antigen/blood ; Female ; Humans ; Lymphatic Metastasis/pathology ; Male ; Middle Aged ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Cribriform carcinoma in the lymph nodes is associated with distant metastasis, recurrence, and survival among patients with node-positive colorectal cancer.
Autorzy:
Yokoyama S; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Fujita Y; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Matsumura S; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Yoshimura T; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Kinoshita I; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Watanabe T; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Tabata H; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Tsuji T; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Ozawa S; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Tamaki T; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Nakatani Y; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Oka M; Department of Surgery, National Hospital Organization Minami Wakayama Medical Centre, Wakayama, Japan.
Pokaż więcej
Źródło:
The British journal of surgery [Br J Surg] 2021 Apr 05; Vol. 108 (3), pp. e111-e112.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphatic Metastasis*
Adenocarcinoma/*mortality
Adenocarcinoma/*pathology
Colorectal Neoplasms/*mortality
Colorectal Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Prognosis ; Young Adult
Czasopismo naukowe
Tytuł:
TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain.
Autorzy:
Ru Q; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.; Department of Health and Kinesiology, School of Physical Education, Jianghan University, Wuhan, China.
Lu Y; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
Saifullah AB; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
Blanco FA; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.; Integrative Molecular and Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, Texas, USA.
Yao C; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
Cata JP; Department of Anesthesiology and Perioperative Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Li DP; Center for Precision Medicine, Department of Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Tolias KF; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
Li L; Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.; Division of Molecular and Translational Biomedicine, Department of Anesthesiology and Perioperative Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2022 Dec 15; Vol. 132 (24). Date of Electronic Publication: 2022 Dec 15.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Chronic Pain*/drug therapy
Ketamine*/pharmacology
T-Lymphoma Invasion and Metastasis-inducing Protein 1*/genetics
T-Lymphoma Invasion and Metastasis-inducing Protein 1*/metabolism
Animals ; Mice ; Antidepressive Agents/pharmacology ; Depression/drug therapy ; Depression/genetics ; Neuronal Plasticity
Czasopismo naukowe
Tytuł:
Obesity promotes lipid accumulation in lymph node metastasis of gastric cancer: a retrospective case‒control study.
Autorzy:
Xiao J; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Shen K; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Liu K; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Wang Y; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Fan H; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Cheng Q; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Zhou X; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Hu L; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Wang G; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Xu Z; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Yang L; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China. .; Department of General Surgery, Liyang People's Hospital, Liyang Branch Hospital of Jiangsu Province Hospital, Liyang, Jiangsu Province, China. .
Pokaż więcej
Źródło:
Lipids in health and disease [Lipids Health Dis] 2022 Nov 17; Vol. 21 (1), pp. 123. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphatic Metastasis*
Obesity*/complications
Obesity*/genetics
Stomach Neoplasms*/genetics
Stomach Neoplasms*/pathology
Female ; Humans ; Middle Aged ; Case-Control Studies ; Lipids ; Retrospective Studies ; Cholesterol, LDL
Czasopismo naukowe
Tytuł:
Metastatic recurrence in colorectal cancer arises from residual EMP1 cells.
Autorzy:
Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Cortina C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Palomo-Ponce S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Mulholland EJ; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.
Turon G; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Conti S; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Roman O; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Stork D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Berenguer-Llergo A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Álvarez-Varela A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Fenderico N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Jiménez-Gracia L; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sipka T; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Bardia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Lorden P; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Colombelli J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Heyn H; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Trepat X; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Tejpar S; Digestive Oncology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
Tauriello DVF; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Leedham S; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Oxford National Institute for Health Research Biomedical Research Centre, Oxford, UK.
Attolini CS; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Batlle E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. .; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. .; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. .
Pokaż więcej
Źródło:
Nature [Nature] 2022 Nov; Vol. 611 (7936), pp. 603-613. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/therapy
Neoplasm Proteins*/deficiency
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/prevention & control
Neoplasm Recurrence, Local*/therapy
Neoplasm, Residual*/genetics
Neoplasm, Residual*/pathology
Receptors, Cell Surface*/deficiency
Receptors, Cell Surface*/genetics
Receptors, Cell Surface*/metabolism
Neoplasm Metastasis*/genetics
Neoplasm Metastasis*/pathology
Neoplasm Metastasis*/prevention & control
Neoplasm Metastasis*/therapy
Animals ; Humans ; Mice ; Disease Progression ; Disease Models, Animal ; T-Lymphocytes/cytology ; T-Lymphocytes/immunology ; Lymphocytes, Tumor-Infiltrating/cytology ; Lymphocytes, Tumor-Infiltrating/immunology ; Neoadjuvant Therapy ; Immunotherapy
Czasopismo naukowe
Tytuł:
Genomics to select treatment for patients with metastatic breast cancer.
Autorzy:
Andre F; Department of Medical Oncology, Gustave Roussy, Villejuif, France. .; INSERM U981, Gustave Roussy, Villejuif, France. .; PRISM Center for personalized medicine, Gustave Roussy, Villejuif, France. .; Medical School, Université Paris Saclay, Kremlin Bicetre, France. .
Filleron T; Department of Biostatistics, Institut Claudius Regaud, IUCT oncopole, Toulouse, France.
Kamal M; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
Mosele F; INSERM U981, Gustave Roussy, Villejuif, France.
Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Dalenc F; Department of Medical Oncology, Institut Claudius-Regaud IUCT oncopole and University of Paul Sabatier, Toulouse, France.
Sablin MP; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.; Department of Medical Oncology, Institut Curie, Paris, France.
Campone M; Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, University of Angers, Angers, France.
Bonnefoi H; Department of Medical Oncology, Institut Bergonié INSERM U1218 and Université of Bordeaux, Bordeaux, France.
Lefeuvre-Plesse C; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Institut de Recherche en Cancérologie de Montpellier INSERM U1194 and Montpellier University, Montpellier, France.
Coussy F; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France.
Emile G; Department of Medical Oncology, Centre François Baclesse, Caen, France.
Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
Thery JC; Department of Medical Oncology, Centre Hennri Becquerel, University of Medicine of Rouen, Rouen, France.
Isambert N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
Mege A; Institut Sainte Catherine, Avignon, France.
Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
You B; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Hajjaji N; Department of Medical Oncology, Centre Oscar Lambret INSERM U1192 PRISM Laboratory and University of Lille, Lille, France.
Lacroix L; Cancer Genetics Laboratory, Department of Pathology and Medical Biology, Gustave Roussy, Villejuif, France.
Rouleau E; Cancer Genetics Laboratory, Department of Pathology and Medical Biology, Gustave Roussy, Villejuif, France.
Tran-Dien A; INSERM U981, Gustave Roussy, Villejuif, France.; PRISM Center for personalized medicine, Gustave Roussy, Villejuif, France.; Bioinformatic Core Facility, UMS AMMICA, Gustave Roussy, Villejuif, France.
Boyault S; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
Attignon V; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
Gestraud P; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.
Servant N; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.
Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
Cherif LL; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
Soubeyran I; Unit of Molecular Pathology - Department of Biopathology, Institut Bergonié, Bordeaux, France.
Montemurro F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Morel A; Department of Innate Immunity and Immunotherapy, Institut de Cancérologie de l'Ouest - Centre Paul Papin, Angers, France.
Lusque A; Department of Biostatistics, Institut Claudius Regaud, IUCT oncopole, Toulouse, France.
Jimenez M; Unicancer, Paris, France.
Jacquet A; Unicancer, Paris, France.
Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Bieche I; Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France.
Pokaż więcej
Źródło:
Nature [Nature] 2022 Oct; Vol. 610 (7931), pp. 343-348. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Clinical Decision-Making*/methods
Genome, Human*/genetics
Genomics*
Neoplasm Metastasis*/drug therapy
Neoplasm Metastasis*/genetics
Neoplasm Metastasis*/pathology
DNA Mutational Analysis ; Disease Progression ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Humans ; Phthalazines/therapeutic use ; Piperazines/therapeutic use
Czasopismo naukowe
Tytuł:
Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.
Autorzy:
Kotepui KU; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Medical Technology Program, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Obchoei S; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Department of Biochemistry, Faculty of Science, Prince of Songkla University, Songkhla 90110, Thailand.
Vaeteewoottacharn K; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Okada S; Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University, 860-0811, Japan.
Wongkham S; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Sawanyawisuth K; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Pokaż więcej
Źródło:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Feb 01; Vol. 23 (2), pp. 715-721. Date of Electronic Publication: 2022 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Annexin A1/*genetics
Bile Duct Neoplasms/*genetics
Cholangiocarcinoma/*genetics
Neoplasm Metastasis/*genetics
Bile Ducts/metabolism ; Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Humans ; Immunohistochemistry ; Lymphatic Metastasis/genetics ; Neoplasm Invasiveness/genetics ; Prognosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz